/
/
/

Gennex Laboratories Profit & Loss

Consolidated
Standalone
Quarterly
Yearly
₹
%
Name
Net Revenue
Other Income
Total Revenue
Total Expenditure
Operating Profit
Interest Expense
PBT
Net Profit
Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Dec 2021Sep 2021Jun 2021Dec 2020Sep 2020Jun 2020Dec 2019Sep 2019Jun 2019Mar 2019Dec 2018Sep 2018Jun 2018Dec 2017Sep 2017
₹40 Cr₹61 Cr₹43 Cr₹39 Cr₹34 Cr₹40 Cr₹40 Cr₹33 Cr₹28 Cr₹34 Cr₹21 Cr₹18 Cr₹16 Cr₹19 Cr₹15 Cr₹20 Cr₹14 Cr₹17 Cr₹14 Cr₹10 Cr₹16 Cr₹15 Cr₹13 Cr₹15 Cr₹14 Cr₹16 Cr₹20 Cr₹15 Cr₹11 Cr₹9 Cr₹12 Cr₹10 Cr
₹2 Cr₹1 Cr₹0₹0₹2 Cr₹4 Cr₹0₹0₹2 Cr₹2 Cr₹0₹0₹3 L₹2 Cr₹0₹0₹57 L₹0₹0₹3 L₹0₹0₹15 L₹0₹0₹34 L₹25 L₹0₹0₹14 L₹0₹3 L
₹42 Cr₹62 Cr₹43 Cr₹39 Cr₹36 Cr₹44 Cr₹40 Cr₹33 Cr₹31 Cr₹36 Cr₹21 Cr₹18 Cr₹17 Cr₹21 Cr₹15 Cr₹20 Cr₹15 Cr₹17 Cr₹14 Cr₹10 Cr₹16 Cr₹15 Cr₹13 Cr₹15 Cr₹14 Cr₹16 Cr₹21 Cr₹15 Cr₹11 Cr₹10 Cr₹12 Cr₹11 Cr
₹36 Cr₹56 Cr₹35 Cr₹32 Cr₹30 Cr₹39 Cr₹33 Cr₹26 Cr₹25 Cr₹29 Cr₹17 Cr₹13 Cr₹12 Cr₹18 Cr₹13 Cr₹18 Cr₹13 Cr₹16 Cr₹13 Cr₹9 Cr₹14 Cr₹14 Cr₹13 Cr₹14 Cr₹13 Cr₹15 Cr₹19 Cr₹14 Cr₹10 Cr₹9 Cr₹11 Cr₹10 Cr
₹6 Cr₹7 Cr₹9 Cr₹8 Cr₹7 Cr₹6 Cr₹7 Cr₹7 Cr₹7 Cr₹6 Cr₹5 Cr₹6 Cr₹5 Cr₹4 Cr₹2 Cr₹2 Cr₹1 Cr₹1 Cr₹2 Cr₹2 Cr₹2 Cr₹2 Cr₹89 L₹81 L₹1 Cr₹2 Cr₹2 Cr₹1 Cr₹89 L₹88 L₹94 L₹81 L
₹90 L₹1 Cr₹1 Cr₹1 Cr₹98 L₹1 Cr₹84 L₹1 Cr₹73 L₹73 L₹83 L₹78 L₹73 L₹63 L₹18 L₹36 L₹26 L₹14 L₹24 L₹15 L₹14 L₹23 L₹16 L₹17 L₹18 L₹23 L₹20 L₹26 L₹17 L₹17 L₹15 L₹20 L
₹5 Cr₹5 Cr₹7 Cr₹6 Cr₹6 Cr₹4 Cr₹6 Cr₹6 Cr₹6 Cr₹5 Cr₹4 Cr₹4 Cr₹4 Cr₹3 Cr₹1 Cr₹1 Cr₹1 Cr₹1 Cr₹2 Cr₹1 Cr₹2 Cr₹1 Cr₹51 L₹34 L₹75 L₹1 Cr₹1 Cr₹82 L₹48 L₹47 L₹51 L₹40 L
₹5 Cr₹4 Cr₹6 Cr₹6 Cr₹5 Cr₹3 Cr₹5 Cr₹5 Cr₹5 Cr₹4 Cr₹3 Cr₹3 Cr₹3 Cr₹2 Cr₹1 Cr₹1 Cr₹75 L₹79 L₹1 Cr₹95 L₹1 Cr₹87 L₹37 L₹20 L₹56 L₹80 L₹45 L₹82 L₹48 L₹47 L₹31 L₹40 L

Share Price Live Stats

Open (₹)8.43
Volume (₹)3.22 L
High (₹)8.99
Upper Circuit9.85
Low (₹)8.30
Lower Circuit6.57
Prev Close8.21
52W High (₹)16.70
Price8.77
52W Low (₹)7.05

Share Market Cap & Key Ratios Overview

M.Cap (₹)199.46 Cr
Div. Yield (%)0.00
PE Ratio10.28
Debt to Equity0.36
Price to Book0.78
Book Value9.16
EPS (TTM)0.80
Face Value1.00
ROE (%)10.40

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
SUNPHARMA-ANSE
DIVISLAB-ANSE
TORNTPHARM-ANSE
LAURUSLABS-ANSE
ZYDUSLIFE-ANSE
DRREDDY-ANSE
CIPLA-ANSE
MANKIND-ANSE
AUROPHARMA-ANSE
LUPIN-ANSE
GENNEX-XNSE
LTP
1W Low
1W High
Market cap (₹)
1771.95-6.3 (-0.35%)
1720.80
1854.80
4,24,202Cr
10030+315 (3.24%)
9622.85
10035
2,64,141Cr
4635-0.15 (-0.00%)
4555
4668.55
1,74,402Cr
2320-72 (-3.01%)
2207.10
2442
1,26,811Cr
1239-5 (-0.40%)
1184.55
1264.20
1,23,685Cr
1370+19.8 (1.47%)
1337.30
1390.70
1,11,868Cr
1392.2+12.2 (0.88%)
1360.60
1392.20
1,11,650Cr
2477.1-11.65 (-0.47%)
2457.35
2527.80
1,02,196Cr
1699+21.2 (1.26%)
1650.10
1699
96,951Cr
2012+3 (0.15%)
1974.05
2032
91,301Cr
8.77+0.75 (9.35%)
7.70
9.12
199Cr

Key Highlights of Gennex Laboratories Ltd’s P&L

In 2025-03-31, Gennex Laboratories Ltd reported total revenue of ₹148.35Cr, compared with ₹91.62Cr in 2024-03-31, reflecting Gennex Laboratories Ltd turnover.

Depreciation was ₹1.99Cr and finance costs were ₹3.61Cr in 2025-03-31

Profit Before Tax (PBT) has been ₹21.4Cr in 2025-03-31 as compared to ₹16.49Cr in 2024-03-31.

Net Profit (PAT) was ₹18.12Cr in 2025-03-31 compared with ₹11.37Cr in 2024-03-31.

Earnings per share (EPS) were ₹0.80 in 2025-03-31, compared with ₹0.50 in 2024-03-31.